Today: 15 May 2026
Robinhood Stock Surges After Bernstein’s $130 Call, but Truist Flags Revenue Pressure
14 April 2026
1 min read

Robinhood Stock Surges After Bernstein’s $130 Call, but Truist Flags Revenue Pressure

NEW YORK, April 14, 2026, 4:05 PM EDT

Robinhood stock surged about 10% Tuesday, trading around $78.75, after Bernstein stuck to its Outperform rating and kept its $130 price target. That follows Truist’s move the previous day—Truist trimmed its target to $100, but maintained its Buy call.

The split is significant, with Robinhood set to release first-quarter earnings on April 28. The central question: Can crypto trading and prediction markets push revenue higher even in a slower quarter? Prediction markets—essentially event contracts—let users bet on outcomes like sports or election results.

Bernstein is looking well above the Street for Robinhood in 2026: revenue forecasts are up 9% versus consensus, and its EPS projection is 16% higher. Part of that comes from a bullish crypto revenue estimate—31% ahead of what the consensus expects. The firm also flagged its estimates for Robinhood’s other transaction revenue, including prediction markets, running about 30% above consensus.

Bernstein analysts, with Gautam Chhugani at the helm, described prediction markets as “broader information markets” in a recent sector note. Their forecast: annual volume hitting $240 billion in 2026, then exploding to $1 trillion by 2030. The note also pointed out that Robinhood acts as Kalshi’s main distribution partner, already listing over 1,000 contracts. Benzinga

Robinhood has thrown some weight behind the bulls. Back in February, the company reported 2025 revenue jumped 52% to a record $4.5 billion. Funded accounts hit 27 million, platform assets swelled to $324 billion, and over 12 billion event contracts traded over the past year. CEO Vlad Tenev, speaking in January, described the market as being in the “early stages of a supercycle.” Robinhood Markets, Inc.

Even so, the latest operating numbers show some bumps. Platform assets in February slipped 3% from January, landing at $314 billion. Event contract activity sank 29% month over month to 2.4 billion. Robinhood’s crypto volume for March, through the 27th, totaled roughly $16 billion.

That goes some way toward illustrating Truist’s decision. Analyst David Smith lowered his target, factoring February and March trading numbers into his model and shaving his 2026–2028 forecasts. Transaction-based revenue was weaker, and while buybacks picked up and operating expenses edged down, it wasn’t enough to fully make up the gap.

Crypto stocks caught a tailwind too. Bitcoin hovered around $74,264, with Coinbase ticking up as well—a sign that Robinhood remains tethered to digital-asset sentiment, despite ongoing efforts to diversify its offerings.

The bullish narrative could unravel in a hurry. Despite Tuesday’s gains, Robinhood is still trading nearly 49% under its 52-week peak of $153.86. Legal headwinds persist for the event-contract business, with state and federal authorities still at odds over whether to classify such products as derivatives or gambling. The Ninth Circuit will take up an appeal involving Kalshi, Robinhood, and Crypto.com on April 16.

Robinhood signed off on a fresh $1.5 billion buyback back on March 24. Investors won’t need to wait long to see if Bernstein or Truist has the sharper near-term read: first-quarter results drop April 28, after the bell.

Stock Market Today

  • RenovoRx Q1 Loss Matches Estimates, Revenue Beats Expectations
    May 14, 2026, 6:48 PM EDT. RenovoRx, Inc. (RNXT) reported a first-quarter loss of $0.08 per share, aligning with Zacks Consensus Estimates. Revenue came in at $0.56 million, exceeding estimates by 12.6% and showing growth from $0.2 million a year ago. The company has missed EPS estimates over the past year but outperformed revenue forecasts twice in four quarters. Despite this, RNXT shares have gained only around 1% year-to-date, compared to the S&P 500's 8.8% rise. The stock holds a Zacks Rank #3 (Hold), indicating expected market-line performance ahead. Investors will watch management's commentary and revisions to earnings forecasts closely, given the Medical - Biomedical and Genetics industry ranks in the bottom 41% among 250 industries by Zacks.

Latest articles

Amazon Stock Falls Today: Why AMZN Slipped While Tech Hit Fresh Highs

Amazon Stock Falls Today: Why AMZN Slipped While Tech Hit Fresh Highs

15 May 2026
Amazon shares fell 1.1% to $267.22 on Thursday, underperforming record highs in the S&P 500 and Nasdaq. Investors focused on Amazon’s rising AI and cloud spending, with little expectation of relief from lower U.S. rates. First-quarter revenue rose 17% to $181.5 billion, but free cash flow dropped sharply due to higher capital spending.
Unusual Machines Stock Jumps As Q1 Revenue Nearly Quadruples And Drone Supply Bet Widens

Unusual Machines Stock Jumps As Q1 Revenue Nearly Quadruples And Drone Supply Bet Widens

15 May 2026
Unusual Machines reported first-quarter revenue of $8.1 million, up 296% from a year earlier, and net income of $10.3 million driven by investment gains despite an operating loss. Shares rose 12.8% to $16.93 after the results. The company raised $150 million in equity and agreed to buy battery maker DroneNX for up to $52 million. Headcount rose to over 190 as of Thursday.
Microsoft Stock Rises As AI Trade Reignites: Why MSFT Shares Moved Today

Microsoft Stock Rises As AI Trade Reignites: Why MSFT Shares Moved Today

15 May 2026
Microsoft shares rose 1.04% to $409.43 on Thursday as investors favored large tech stocks amid record highs for the S&P 500 and Nasdaq. Microsoft reported March-quarter revenue up 18% to $82.9 billion, with Azure and cloud services up 40%. The company expects $190 billion in capital expenditures this year, well above analyst estimates. Microsoft is also exploring AI startup deals as it reassesses its reliance on OpenAI.
United States Antimony Stock Falls After $11.3 Million Loss as Defense Contract Ramp Awaits

United States Antimony Stock Falls After $11.3 Million Loss as Defense Contract Ramp Awaits

15 May 2026
United States Antimony posted a first-quarter net loss of $11.3 million, or 8 cents a share, on $6.8 million in revenue, down from a $546,524 profit a year earlier. Shares fell about 4% to $9.57 in late trading. The company completed initial deliveries under a $245 million Defense Logistics Agency contract but did not recognize revenue from it in the quarter. Gross profit dropped to $1.1 million from $2.4 million.
Natural Gas Price Today: Henry Hub Slides, Europe’s TTF Tumbles as Mild Weather Cuts Demand
Previous Story

Natural Gas Price Today: Henry Hub Slides, Europe’s TTF Tumbles as Mild Weather Cuts Demand

Broadcom Stock Gets Fresh Meta AI Lift as Duolingo Stock Falls on Growth Fears
Next Story

Broadcom Stock Gets Fresh Meta AI Lift as Duolingo Stock Falls on Growth Fears

Go toTop